Byssochlamysol, a new antitumor steroid against IGF-1-dependent cells from Byssochlamys nivea. I. Taxonomy, fermentation, isolation and biological activity

Journal of Antibiotics

Volumn 56, Issue 1, 2003, Pages 1-5

  Mori, Toshiya ^a   Shin ya, Kazuo ^a   Aihara, Maki ^b   Takatori, Kosuke ^b   Hayakawa, Yoichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BYSSOCHLAMYSOL; SOMATOMEDIN C; STEROID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; BYSSOCHLAMYS NIVEA; CANCER CELL CULTURE; CELL GROWTH; CELL STRAIN MCF 7; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG ISOLATION; DRUG STRUCTURE; FUNGUS; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; MYCELIUM; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

BYSSOCHLAMYS NIVEA;

EID: 0037273206     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.56.1     Document Type: Article

References (9)

1. POLLACK, M. N.: Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention. Breast Cancer Treat. Res. 58: 209-217, 1998
2. HANKINSON, S. E.; W. C. WILLETT, G. A. COLDITZ, D. J. HUNTER, D. S. MICHAUD, B. DEROO, B. ROSNER, F. E. SPEIZER & M. POLLAK: Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351: 1393-1396, 1998
3. WU, Y.; S. YAKAR, L. ZHAO, L. HENNIGHAUSEN & D. LEROITH: Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res. 62: 1030-1035, 2002
4. BASERGA, R.; A. HONGO, M. RUBINI, M. PRISCO & B. VALENTINIS: The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta 1332: F105-F126, 1997
5. CHERNICKY, C. L.; H. TAN, L. YI, J. R. LORET DE MOLA & J. ILAN: Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo. Mol. Pathol. 55: 102-109, 2002
6. SELL, C.; M. RUBINI, R. RUBIN, J.-P. LIU, A. EFSTRATIADIS & R. BASERGA: Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc. Natl. Acad. Sci. USA 90: 11217-11221, 1993
7. NEUENSCHWANDER, S.; C. T. ROBERTS Jr. & D. LEROITH: Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid. Endocrinology 136: 4298-4303, 1995
8. MORI, T.; K. SHIN-YA, K. TAKATORI, M. AIHARA & Y. HAYAKAWA: Byssochlamysol, a new antitumor steroid against IGF-1-dependent cells from Byssochlamys nivea. II. Physico-chemical properties and structure elucidation. J. Antibiotics 56: 6-8, 2003
9. SAMSON, R. A. & E. S. HOEKSTRA: Introduction to Food-Borne Fungi, pp. 26-31, Centraalbureau voor Schimmelcultures Baarn, 1988